drugset / Trial / NCT00437359
Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate the benefit of postoperative adjuvant therapy using sequential administration of the hormone, toremifene citrate (TOR) or anastrozole (ANA), after chemotherapy in breast cancer.
Timeline
- Start
- 2007-05
- Primary completion
- 2017-05
- Completion
- 2020-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | 1 mg | Oral |
| Subject | Toremifene | Small molecule | 40 mg | Oral |